Red Pharma Laboratories Polska

8 records, newest first. Each line links to the FDA page it came from.

Refusal charges, in plain English

• LABELING8 refused lines

  Fair Packaging and Labeling Act

  The package appeared not to meet the Fair Packaging and Labeling Act because of the placement, form, or contents of a required label statement.

• NUTRIT LBL2 refused lines

  Nutrition information missing from label

  The label or labeling appeared not to carry the nutrition information that U.S. law requires for the food.

• INCONSPICU1 refused line

  Required information not conspicuous

  Information required on the label appeared not to be placed prominently or conspicuously enough to be read and understood by an ordinary consumer.

• NCONTACT1 refused line

  No U.S. adverse event contact on supplement label

  The dietary supplement label appeared not to show a U.S. address or phone number through which a serious adverse event can be reported.

Questions about Red Pharma Laboratories Polska

Is Red Pharma Laboratories Polska on an FDA import alert?

No listing for Red Pharma Laboratories Polska appears in the FDA import alerts SupplierRadar checked on October 26, 2026. Country-wide alerts may still apply to its products; see the Poland page.

Has FDA refused shipments from Red Pharma Laboratories Polska?

Yes. FDA refused 8 shipment lines from Red Pharma Laboratories Polska on October 23, 2024. The most recent, on October 23, 2024, was vitamin, mineral, proteins and unconventional dietary specialities for humans and animals, n.e.c., charged as LABELING (fair packaging and labeling act).

Why did FDA refuse Red Pharma Laboratories Polska's shipments?

The most frequent charges are LABELING (fair packaging and labeling act, 8 lines) and NUTRIT LBL (nutrition information missing from label, 2 lines).

What is Red Pharma Laboratories Polska's FEI number?

Red Pharma Laboratories Polska's FDA Establishment Identifier (FEI) is 3031917025.